References
- Weil CR, Parsons MJ, Hutten RJ, et al. Patterns of care and outcomes of early stage I-Hodgkin lymphoma treated with or without radiation therapy. Leuk Lymphoma. 2022;1–11.
- Olszewski AJ, Shrestha R, Castillo JJ. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base. J Clin Oncol. 2015;33(6):625–633.
- Parikh RR, Grossbard ML, Harrison LB, et al. Early-Stage classic Hodgkin lymphoma: the utilization of radiation therapy and its impact on overall survival. Int J Radiat Oncol Biol Phys. 2015;93(3):684–693.
- Andre MPE, Girinsky T, Federico M, et al. Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 2017;35(16):1786–1794.
- Fuchs M, Goergen H, Kobe C, et al. Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the german Hodgkin study group. J Clin Oncol. 2019;37(31):2835–2845.
- Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma. N Engl J Med. 2015;372(17):1598–1607.
- Jones DA, Candio P, Shakir R, et al. Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry. Blood Adv. 2022;6(3):909–919.
- Pinnix CC, Gunther JR, Fang P, et al. Assessment of radiation doses delivered to organs at risk among patients with early-stage favorable Hodgkin lymphoma treated with contemporary radiation therapy. JAMA Netw Open. 2020;3(9):e2013935.